Shashi Gujar

[Shashi Gujar @Gujarlab]

We are hiring post-doctoral fellow and/or research associate in Cancer immunology & immunotherapy at Dalhousie University, Halifax, Canada! Please share the attached advertisement with anyone interested. @CCIConsortium @CdnImmunol @NatImmunol @SciImmunology @SRC_CRS

[Shashi Gujar @Gujarlab]

Congratulation to our PhD student @GiacoMikeTonio on his doctoral (PhD) degree convocation! Our hearty wishes towards the bright future Mike! Cheers

[Shashi Gujar @Gujarlab]

https://t.co/XaQwLco5qm
We are honored and excited to be featured by CIHR!
@DalhousieU , @DalMedSchool , @dmrf1979 , @CIHR_ICR , @CCSResearch , @BHCRI , @DalPathology
https://t.co/iYcY6KXh5b

[IIT ROPAR @iitrpr]

Prof. Rajeev Ahuja shared that the main aim of this collaboration is to give IIT Ropar researchers an advantage of joint doctoral program which will give them international exposure of talent and knowledge economy.

[katherinerisley @KatherineRisley]

Thanks to the @halifaxchamber for bringing four impressive examples of global health problems that are being solved here in Halifax. Yet another driver of economic growth across the region. #HCCBREAKTHROUGHS

[Halifax Chamber @halifaxchamber]

1 in 2 people will receive a cancer diagnosis in their life. Can we strength-train our immune systems to face change this statistic?

Dr. Shashi Gujar talks cutting-edge innovations and effective cancer therapies at the 2022 Annual Spring Dinner!

@Gujarlab

#HCCBreakthroughs

[Shashi Gujar @Gujarlab]

https://t.co/M5Zc17cHqV

[Halifax Chamber @halifaxchamber]

We are honoured to be hosting such an innovative group of speakers at our Annual Spring Dinner on May 4, 2022.

Register today at:
https://t.co/irWSla7h8Z

-

Thank you to our sponsors:
@OlandBrewery @mcinnescooper @Deloitte @TD_Canada @DalMedSchool @DalhousieU @CNRailway @nsgov

[Halifax Chamber @halifaxchamber]

We are honoured to be hosting such an innovative group of speakers at our Annual Spring Dinner on May 4, 2022.

Register today at:
https://t.co/irWSla7h8Z

-

Thank you to our sponsors:
@OlandBrewery @mcinnescooper @Deloitte @TD_Canada @DalMedSchool @DalhousieU @CNRailway @nsgov

[Halifax Chamber @halifaxchamber]

🦠How can we use COVID-19 to cure cancer?

Ask Dr. Shashi Gujar at our upcoming Spring Dinner!

Register here➡️ https://t.co/gAG5Tz5gTT

[Shashi Gujar @Gujarlab]

Congratulations to our PhD grad (Dr.) Youra Kim and all the co-authors on this paper! Exciting discoveries in cancer immunotherapy area! We are thankful to supports from @dmrf1979 @CIHR_ICR @DalPathology @Dal_micro_immun @CCSResearch

[Dalhousie Pathology @DalPathology]

Check out the latest from @Gujarlab et al!

[Shashi Gujar @Gujarlab]

Mentors change lives ! We are honored to be part of this publication as part of Irving Symposium @dmrf1979 @DalPathology @DalhousieU @Dal_micro_immun .

Supporting the Next Generation of Scientists to Lead Cancer Immunology Research https://t.co/RcDW1UWXUB

[Trends in Cancer @trendscancer]

Targeting NAD+ synthesis to potentiate CD38-based immunotherapy of multiple myeloma #TRECANeditorspicks @trendscancer, @Gujarlab, @DalhousieU https://t.co/5kJnrmfd7G

[Shashi Gujar @Gujarlab]

It was an honor to chair today's 'Immunotherapy' session at during the first day of @CCRAconf. Fantastic talks by @IanWatsonLab , Simon Milette and Brian Laight @dmrf1979, @DalPathology, @mcgillu , @DalhousieU

[Shashi Gujar @Gujarlab]

Thank you @dmrf for supporting this international initiative. @DalPathology , @Dal_micro_immun , @DalhousieU , @DalMedSchool
https://t.co/hCBWyAotnP

[Shashi Gujar @Gujarlab]

We are honored to be part of this international collaboration!
https://t.co/IDMO17wu07

[Shashi Gujar @Gujarlab]

Cancer immuno-surveillance via autoimmunity: Check out this cool paper from our collaborators Drs. Guido Kroemer and Jo Pol @Inserm published in @JExpMed
Glad to be part of this study!
@DalPathology @Dal_micro_immun @DalhousieU @BHCRI @dmrf1979
https://t.co/iEnYHJsLXL

[Journal of Experimental Medicine @JExpMed]

Paillet, Kroemer, Pol et al @Inserm show in murine models that #autoimmunity, which targets normal cholangiocytes upon primary biliary cholangitis, fuels the immunosurveillance of malignant cholangiocytes & protects from the emergence of cholangiocarcinoma https://t.co/4zsXAIDObq

[Rockefeller U. Press @RockUPress]

In @JExpMed, Paillet et al @Inserm show in murine models that #autoimmunity, which targets normal cholangiocytes upon primary biliary cholangitis, fuels the immunosurveillance of malignant cholangiocytes & protects from the emergence of cholangiocarcinoma https://t.co/OgFKoWEDau

[BHCRI Research @BHCRI]

Save the date. Monday Sept 20 is the launch of @tfri_research Pan-Can Seminar Series. Featured speaker Dr. Christian Steidl "Understanding the biology of relapse in treatment failure in lymphoma - the keys to clinical translation". Registration info coming soon.